Question follow-through · 12794

Prostate Cancer: Screening

To ask the Secretary of State for Health and Social Care, whether the UK National Screening Committee plans to build use of Stockholm3 into its screening model.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body: Department of Health and Social Care
Tabled: 24 Jun 2026
Target answer date: 29 Jun 2026
Answer: 1 Jul 2026 · 7 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

Votes on this topic

Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
Health Bill: Report Stage: New Clause 143 · 8 Sept 2026

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

24 Jun 2026
Question tabled
To ask the Secretary of State for Health and Social Care, whether the UK National Screening Committee plans to build use of Stockholm3 into its screening model.
29 Jun 2026
Target answer date
Date supplied by the official written-questions record.
1 Jul 2026
Answer published
The UK National Screening Committee (UK NSC) has committed to examine any significant peer reviewed evidence that is relevant to its recommendation on prostate cancer screening, including reviewing evidence on biomarkers such as Stockholm3.When new peer r...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Strong linkSame MP, department and exact heading